“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

The stages also act as a guide to when certain treatments, such as medicines for Alzheimer’s disease, are likely to work best. The stages of dementia are just a guide and there is nothing significant ...

The most prevalent cause of dementia is a progressive neurological disease called Alzheimer's disease. It steadily becomes worse over time and affects thinking, memory, and behaviour. Alzheimer's ...

3, 2024 — An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease ... in Alzheimer's early stages, revealing potential ...

Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...

CINCINNATI (WXIX) -Over 2,000 gathered at Sawyer Point for the annual Walk to End Alzheimer’s, raising over $600,000 for the ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

Eli Lilly LLY announced that its Alzheimer's ... disease compared to placebo at 18 months. It also showed that Kisunla reduced participants' risk of progressing to the next clinical stage of ...

Today, Benzinga 's options scanner spotted 15 uncommon options trades for Cassava Sciences. This isn't normal. The overall ...

AbbVie's acquisition of Cerevel Therapeutics strengthens its neuroscience pipeline with promising candidates, making ABBV a ...

Cassava on Tuesday announced a milestone in a late-stage trial of an ... dramatic improvements in biomarkers associated with Alzheimer's disease." The SEC also alleges that Wang knew Cassava ...

Following our analysis of the options activities associated with Cassava Sciences, we pivot to a closer look at the company's ...